Composition for regulating bone metabolism
The present invention provides a composition for regulating bone metabolism that comprises proanthocyanidins. It is preferable that the proanthocyanidins in this composition for regulating bone metabolism are contained in an extract deri...
K Takagaki，T Mitsui - US
Nasal administration of the lh-rh analog leuprolide
not available
K Iqbal，A Fisher，P Watts - CA
Use of ras inhibitors of inhibiting muscle atrophy
not available
DJ Glass，R Christian，GD Yancopoulos - WO
NASAL ADMINISTRATION OF THE LH-RH ANALOG LEUPROLIDE
Angiotensin II (Ang II) AT1 receptors modulate most of the known physiological functions of Ang II in the kidney and cardiovascular structures. In contrast...
I Khurshid，FAAE Centre，WPAE Centre - 《Pediatric Nephrology》
PHARMACEUTICAL COMBINATION OF AN ANTI-ANDROGEN AND TAMOXIFEN FOR PROVIDING AN ANTI-ANDROGENIC EFFECT AND AROMATASE INHIBITION
The present invention relates to a pharmaceutical product, daily dose or dose regimen comprising an anti-androgen and tamoxifen, wherein the anti-androgen is selected from flutamide, nilutamide, chlormadinone acetate and cyproterone or p...
COCKSHOTT Ian，FURR Barrington - US
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlor...
T Jerussi，QK Fang，MG Currie - 《Gazzetta Chimica Italiana》
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
Treatment of central nervous system disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine and with (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine is disclosed....
TP Jerussi，QK Fang，MG Currie - US
Inhibition of angiogenesis through nitric oxide tachyphylaxis
A method is provided for treating cancer in a mammalian subject by inhibiting angiogenesis through the administration to the subject of a therapeutically effective amount of a nitrate-containing compound and a therapeutically effective a...
Bryan T. Oronsky，John W. Sliwa，Herbert L. Berman，... - US
Stable pharmaceutical composition of carisoprodol and meloxicam
The present invention provides a pharmaceutical composition or formulation in the form of tablets of proved stability and describes the obtainment process. This formulation combines the therapeutic action of meloxicam as an anti-inflamma...
AS Regalado，SSE Leon - US
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorop...
T Jerussi，QK Fang，MG Currie - US
